These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12759631)

  • 1. Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer.
    Meacham LR; Mazewski C; Krawiecki N
    J Pediatr Hematol Oncol; 2003 May; 25(5):414-7. PubMed ID: 12759631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression.
    Orme LM; Bond JD; Humphrey MS; Zacharin MR; Downie PA; Jamsen KM; Mitchell SL; Robinson JM; Grapsas NA; Ashley DM
    Cancer; 2003 Jul; 98(2):397-405. PubMed ID: 12872362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low-dose adrenocorticotropin test reveals impaired adrenal function in cancer patients receiving megestrol acetate therapy.
    Ron IG; Soyfer V; Goldray D; Inbar MJ; Weisman Y
    Eur J Cancer; 2002 Jul; 38(11):1490-4. PubMed ID: 12110495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer.
    Dev R; Del Fabbro E; Bruera E
    Cancer; 2007 Sep; 110(6):1173-7. PubMed ID: 17647248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal insufficiency induced by megestrol acetate: Report of two cases.
    García-Castells AM; Argente-Pla M; García-Malpartida K; Querol-Ripoll R; Merino-Torres JF
    Endocrinol Nutr; 2015 Dec; 62(10):515-6. PubMed ID: 26250842
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate.
    Stockheim JA; Daaboul JJ; Yogev R; Scully SP; Binns HJ; Chadwick EG
    J Pediatr; 1999 Mar; 134(3):368-70. PubMed ID: 10064680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate-induced adrenal insufficiency.
    González Villarroel P; Fernández Pérez I; Páramo C; Gentil González M; Carnero López B; Vázquez Tuñas ML; Carrasco Alvarez JA
    Clin Transl Oncol; 2008 Apr; 10(4):235-7. PubMed ID: 18411198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate.
    Chidakel AR; Zweig SB; Schlosser JR; Homel P; Schappert JW; Fleckman AM
    J Endocrinol Invest; 2006 Feb; 29(2):136-40. PubMed ID: 16610239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate induced hypoadrenalism with cushingoid phenotype in endometrial cancer.
    Ozguroglu M; Yildiz O; Turna H; Kadioğlu P
    Gynecol Oncol; 2006 Apr; 101(1):183. PubMed ID: 16414105
    [No Abstract]   [Full Text] [Related]  

  • 10. Megestrol acetate-associated adrenal insufficiency.
    Bulchandani D; Nachnani J; Amin A; May J
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):167-72. PubMed ID: 18775392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of adrenal suppression by megestrol acetate in patients with AIDS.
    Leinung MC; Liporace R; Miller CH
    Ann Intern Med; 1995 Jun; 122(11):843-5. PubMed ID: 7741369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
    Yeh SS; Lovitt S; Schuster MW
    J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.
    Argilés JM; Anguera A; Stemmler B
    Clin Nutr; 2013 Jun; 32(3):319-24. PubMed ID: 23395103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary symptomatic adrenal insufficiency induced by megestrol acetate.
    Delitala AP; Fanciulli G; Maioli M; Piga G; Delitala G
    Neth J Med; 2013 Jan; 71(1):17-21. PubMed ID: 23412818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
    Gebbia V; Testa A; Gebbia N
    Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis.
    Marchand V; Baker SS; Stark TJ; Baker RD
    J Pediatr Gastroenterol Nutr; 2000 Sep; 31(3):264-9. PubMed ID: 10997370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
    Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
    Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
    Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
    J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate therapy and secondary adrenal suppression.
    Naing KK; Dewar JA; Leese GP
    Cancer; 1999 Sep; 86(6):1044-9. PubMed ID: 10491532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.